Overview

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

Status:
Completed
Trial end date:
2019-12-27
Target enrollment:
Participant gender:
Summary
A Therapeutic Exploratory Clinical Study to evaluate the efficacy and safety of DA-8010 in Patients with Overactive Bladder and to determine the optimal dose of DA-8010
Phase:
Phase 2
Details
Lead Sponsor:
Dong-A ST Co., Ltd.
Treatments:
DA-8010
Solifenacin Succinate